𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study

✍ Scribed by Lecumberri, R.; López Vivanco, G.; Font, A.; González Billalabeitia, E.; Gúrpide, A.; Gómez Codina, J.; Isla, D.; Galán, A.; Bover, I.; Domine, M.; Vicente, V.; Rosell, R.; Rocha, E.

Book ID
122490351
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
346 KB
Volume
132
Category
Article
ISSN
0049-3848

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The results of treatment in 100 patients
The results of treatment in 100 patients with limited-stage small cell lung cancer
✍ Xuyi Liu; Xiaokui Li; Yubin Pang; Qingqi Li; Xueyi Wang; Wenjong Shen 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 2 views

## Background: In an attempt to improve treatment results of small cell lung cancer (sclc), combined induction chemotherapy and thoracic and prophylactic brain radiation therapy were administered. ## Method: From december 1980 to december 1987, 112 patients with limited-stage sclc were treated wi

Prognostic significance of serum p53 ant
Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer
✍ Gérard Zalcman; Jean Trédaniel; Beata Schlichtholz; Thierry Urban; Bernard Mille 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 239 KB 👁 2 views

p53 tumour suppressor gene alterations are one of the most frequent genetic events in lung cancer. A subset of patients with p53 mutation and cancer exhibited circulating serum anti-p53 self-antibodies (p53-Ab). The prevalence of these antibodies in lung cancer is currently being analysed in a multi